title: Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor.
abstract: Vigorous activity after diagnosis was recently reported to be inversely associated with prostate cancer-specific mortality. However, men with metastatic disease may decrease their activity due to their disease; thus, a causal interpretation is uncertain. We therefore prospectively examined vigorous activity and brisk walking after diagnosis in relation to risk of prostate cancer progression, an outcome less susceptible to reverse causation, among 1,455 men diagnosed with clinically localized prostate cancer. Cox proportional hazards regression was used to examine vigorous activity, nonvigorous activity, walking duration, and walking pace after diagnosis and risk of prostate cancer progression. We observed 117 events (45 biochemical recurrences, 66 secondary treatments, 3 bone metastases, 3 prostate cancer deaths) during 2,750 person-years. Walking accounted for nearly half of all activity. Men who walked briskly for 3 h/wk or more had a 57% lower rate of progression than men who walked at an easy pace for less than 3 h/wk (HR = 0.43; 95% CI: 0.21-0.91; P = 0.03). Walking pace was associated with decreased risk of progression independent of duration (HR brisk vs. easy pace = 0.52; 95% CI: 0.29-0.91; P(trend) = 0.01). Few men engaged in vigorous activity, but there was a suggestive inverse association (HR ≥3 h/wk vs. none = 0.63; 95% CI: 0.32-1.23; P(trend) = 0.17). Walking duration and total nonvigorous activity were not associated with risk of progression independent of pace or vigorous activity, respectively. Brisk walking after diagnosis may inhibit or delay prostate cancer progression among men diagnosed with clinically localized prostate cancer.
authors: Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.
authors: Erin L
authors: EL
authors: Richman
authors: Stacey A
authors: SA
authors: Kenfield
authors: Meir J
authors: MJ
authors: Stampfer
authors: Alan
authors: A
authors: Paciorek
authors: Peter R
authors: PR
authors: Carroll
authors: June M
authors: JM
authors: Chan
references: Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504
references: 10993420
references: J Cell Biochem. 2008 Apr 1;103(5):1344-53
references: 17955503
references: Int J Cancer. 2007 Oct 1;121(7):1571-8
references: 17450530
references: Prostate. 2003 Aug 1;56(3):201-6
references: 12772189
references: Am J Clin Nutr. 2010 Mar;91(3):712-21
references: 20042525
references: Lancet Oncol. 2008 Nov;9(11):1039-47
references: 18835745
references: Endocrinology. 2003 Jun;144(6):2319-24
references: 12746292
references: Scand J Med Sci Sports. 2008 Dec;18(6):736-41
references: 18248547
references: J Appl Physiol (1985). 2004 Feb;96(2):450-4
references: 14715676
references: J Urol. 2004 Apr;171(4):1393-401
references: 15017184
references: Clin Chem. 2010 Jan;56(1):34-43
references: 19910504
references: Cancer Causes Control. 2006 Mar;17(2):199-208
references: 16425098
references: J Am Geriatr Soc. 2008 Nov;56(11):2045-52
references: 19016938
references: Urology. 1996 Nov;48(5):773-7
references: 8911524
references: Urology. 2002 Sep;60(3 Suppl 1):57-62; discussion 62-3
references: 12231051
references: Arch Physiol Biochem. 2008 Feb;114(1):23-37
references: 18465356
references: Cancer Prev Res (Phila). 2008 Oct;1(5):369-75
references: 19138981
references: Am J Epidemiol. 2009 Apr 15;169(8):937-45
references: 19240222
references: Am J Clin Nutr. 2007 Sep;86(3):s858-66
references: 18265479
references: J Clin Oncol. 2005 Nov 10;23(32):8152-60
references: 16278466
references: J Clin Oncol. 2011 Feb 20;29(6):726-32
references: 21205749
references: J Urol. 2009 Nov;182(5):2232-41
references: 19781717
references: Arch Intern Med. 2001 Jun 25;161(12):1542-8
references: 11427103
references: Int J Cancer. 2009 May 15;124(10):2416-29
references: 19142965
references: JAMA. 2011 Jan 5;305(1):50-8
references: 21205966
references: Int J Cancer. 2009 Jun 1;124(11):2683-9
references: 19189403
references: Cancer. 2008 Jan 15;112(2):307-14
references: 18050294
references: Epidemiology. 1996 Jan;7(1):81-6
references: 8664406
references: Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):306-13
references: 19124513
references: JAMA. 2002 Oct 23-30;288(16):1994-2000
references: 12387651